## AMPX: Amprius Technologies, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -13.6% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-10.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($7.10)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Amprius Expands Korea Battery Alliance with NDAA-Compliant Manufacturing Network**
- Source: Dronelife | 20251216T170913 | Neutral | Relevance: 100%
- Amprius Technologies (NYSE: AMPX) has expanded its Korea Battery Alliance by adding three new contract manufacturers, significantly boosting its global production capacity to over 2 GWh for its SiCoreÂ® battery technology. This expansion strengthens NDAA-compliant supply chains crucial for defense and aerospace applications and reinforces South Korea's role as a hub for advanced battery technology. The initiative aims to accelerate the production of Amprius' high-energy density silicon anode batteries within a secure framework.

**2. Amprius Technologies Sees Stock Volatility Amid Industry Buzz**
- Source: StocksToTrade | 20251217T170909 | Bearish | Relevance: 100%
- Amprius Technologies Inc. (NYSE: AMPX) is experiencing significant stock volatility, with shares trading down by -9.73% due to investor sentiment concerns and recent financial results showing a net loss despite substantial cash-on-hand. Despite challenges like decreasing EBIT margins and rising raw material costs, the company has strong short-term liquidity. The article emphasizes that prudent evaluation, strategic execution, and balancing innovation with financial pragmatism will be crucial for Amprius's future, as traders weigh potential buying opportunities against caution.

**3. Amprius Technologies (NYSE:AMPX) Stock Price Up 2% - Still a Buy?**
- Source: MarketBeat | 20251216T200909 | Neutral | Relevance: 100%
- Amprius Technologies (NYSE: AMPX) saw its stock price rise by 2% on Tuesday, trading at $10.25 with reduced volume. Despite beating recent earnings estimates, the company remains unprofitable with negative net margins. Significant insider selling, including by the CEO, has occurred recently, though analysts maintain a "Moderate Buy" rating with an average target price of $14.29.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.20M) |
| Sells | 2 ($0.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 25.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Blackrock Inc.: 5.7% (+41.5%)
- Vanguard Group Inc: 5.0% (+37.0%)
- Driehaus Capital Man: 2.4% (+100.0%)
- Morgan Stanley: 2.1% (+41.9%)
- Citadel Advisors Llc: 1.9% (+796.4%)

### Key Risks

1. High beta (2.96) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_10 falling (-10.3% 5d) with bearish MACD, trend may be turning.
3. Elevated short interest (10.9%): bears positioning against stock.
4. Near-term weakness: 22.3% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.58 indicates undervaluation relative to growth. Balance sheet: strong liquidity (6.7x). Revenue growth strong at 71% YoY. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1.2B |
| Beta | 2.96 |
| 52W Range | $1.66 - $16.03 |
| Short Interest | 10.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.58 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from -3.4% to -13.6% (-10.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 16.6pp (needs >3.0% for momentum thesis). Underperforming sector by 14.9pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.32x) but short-term weakness (below SMA20). OFD pattern: -DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -13.61% (CS: 1) | Weak |
| RSI_14 | 37.8 | Neutral |
| MACD Histogram | -0.23 | Bearish |
| vs SMA20 | 0.844x | Below |
| vs SMA50 | 0.777x | Below |
| vs SMA200 | 1.320x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $9.14
- **Stop Loss:** $7.10 (22.3% risk)
- **Target:** $11.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 349
- **Position Value:** $3,189.86
- **Portfolio %:** 3.19%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-03-19 (Est: $-0.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.06 | $-0.03 | +47.8% |
| 2025Q2 | $-0.08 | $-0.05 | +37.5% |
| 2025Q1 | $-0.09 | $-0.08 | +11.1% |
| 2024Q4 | $-0.10 | $-0.09 | +16.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*